CORE--EMBRYONIC STEM CELL

$0P01FY2000DKNIH

New York University School Of Medicine, New York NY

Investigators

Linked publications & trials

Paper 31577526 Paper 30303751 Paper 28099513 Paper 28017513 Paper 27044107 Paper 27009205 Paper 26549759 Paper 26350322 Paper 25974133 Paper 25229135 Paper 24914955 Paper 24450554 Paper 23993789 Paper 22323295 Paper 20032263 Paper 19951992 Paper 19577575 Paper 19566896 Paper 19340092 Paper 19267388 Paper 19262691 Paper 18481938 Paper 18355864 Paper 18347076 Paper 18291621 Paper 17938404 Paper 17936789 Paper 17935615 Paper 17707461 Paper 17256055 Paper 17249638 Paper 17158912 Paper 16841935 Paper 16814572 Paper 16785325 Paper 16609152 Paper 16567801 Paper 16330712 Paper 16139432 Paper 15958488 Paper 15920738 Paper 15867343 Paper 15819416 Paper 15734997 Paper 15611339 Paper 15200408 Paper 15106923 Paper 14737103 Paper 14631400 Paper 14625374 Paper 12972502 Paper 12921785 Paper 12517796 Paper 12475947 Paper 12446744 Paper 12388410 Paper 12124355 Paper 12082083 Paper 12060386 Paper 11955018 Paper 11739641 Paper 11360181 Paper 11256943 Paper 11253121 Paper 11136252 Paper 11085999 Paper 10942582

Abstract

Description: (Taken directly from the application) The purpose of Core B is to set up a small tissue culture room dedicated to the growth and handling of embryonic stem (ES) cells that will be used for gene targeting experiments. These experiments are extremely time-consuming, but can be easily ruined by mycoplasma contamination, which exists in many established cell lines being handled in our regular tissue culture rooms. This Core will benefit primarily Project 1, which aims at the knockout of genes encoding some of the uroplakins, Project 4 which will knockout p53 in urothelial cells.

View original record on NIH RePORTER →